GOG 3026 A phase II trial of letrozole + ribociclib in women with recurrent low-grade serous carcinoma of the ovary, fallopian tube or peritoneum: A GOG foundation study (001)

Brian M. Slomovitz, Wei Deng, Josh Killion, S. John Weroha, Floor Backes, David S. Miller, Meaghan Tenney, Tilley Jenkins Vogel, Lee-may Chen, Merry Jennifer Markham, Hye Sook Chon, Robert L. Coleman, David M. Gershenson

2023Gynecologic Oncology22 citationsDOI Open Access PDF

Topics & Concepts

MedicineLetrozoleFallopian tubeOncologyEndocrine systemOvaryClinical trialGynecologyFulvestrantInternal medicineBreast cancerCancerEstrogen receptorTamoxifenHormoneAdvanced Breast Cancer Therapies

GOG 3026 A phase II trial of letrozole + ribociclib in women with recurrent low-grade serous carcinoma of the ovary, fallopian tube or peritoneum: A GOG foundation study (001)

Topics & Concepts

GOG 3026 A phase II trial of letrozole + ribociclib in women with recurrent low-grade serous carcinoma of the ovary, fallopian tube or peritoneum: A GOG foundation study (001)